Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Chemmedchem|July 24, 2010
Synthesis, cytotoxicity, and insight into the mode of action of Re(CO)3 thymidine complexesMark D Bartholomä, Anthony R Vortherms, Shawn Hillier, et al.
Journal of Neuroinflammation|September 22, 2018
Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targetsChuhyon Corwin, Anastasia Nikolopoulou, Allen L Pan, et al.
Bioorganic & Medicinal Chemistry|March 28, 2007
A kit method for the high level synthesis of [211At]MABGGanesan Vaidyanathan, Donna J Affleck, Kevin L Alston, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2010
Phase I trial of 90Y-DOTATOC therapy in children and young adults with refractory solid tumors that express somatostatin receptorsYusuf Menda, M Sue O'Dorisio, Simon Kao, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 22, 2006
Comparison of radiohaloanalogues of meta-iodobenzylguanidine (MIBG) for a combined gene- and targeted radiotherapy approach to bladder carcinomaNatasha E Fullerton, Marie Boyd, Susan C Ross, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2017
Phase 2 Study of <sup>99m</sup>Tc-Trofolastat SPECT/CT to Identify and Localize Prostate Cancer in Intermediate- and High-Risk Patients Undergoing Radical Prostatectomy and Extended Pelvic LN DissectionKarolien E Goffin, Steven Joniau, Peter Tenke, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2017
Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with <sup>131</sup>I-MIP-1095Ali Afshar-Oromieh, Uwe Haberkorn, Christian Zechmann, et al.
Nuklearmedizin. Nuclear Medicine|May 11, 2019
Preclinical evaluation of peptide-based radiotracers for integrin αvβ6-positive pancreatic carcinomaMartin Müller, Annette Altmann, Max Sauter, et al.
JCI Insight|October 23, 2025
FAP PET identifies earlycardiac molecular changesinduced by doxorubicin chemotherapyChul-Hee Lee, Onorina L Manzo, Luisa Rubinelli, et al.
Translational Oncology|October 14, 2021
68Ga-PSMA-HBED-CC PET/MRI is superior to multiparametric magnetic resonance imaging in men with biochemical recurrent prostate cancer: A prospective single-institutional studyJuana Martinez, Kritika Subramanian, Daniel Margolis, et al.
Pageof 3